Physician profile
William Thompson
NPI 1346258829
$306.81
in general payments reported to CMS, 2019-2025
13 companies · $14.31 in 2025
The $14.31 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $33.89 · 2021: $13.65 · 2022: $16.02 · 2023: $24.69 · 2024: $26.13 · 2025: $14.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $65.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $65.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Enterprises LLC | $43.74 | 2019 | |
| Omeros Corporation | $35.33 | 2019 | |
| Ethicon US, LLC | $31.78 | 2019 | |
| Smith+Nephew, INC. | $29.61 | 2019-2025 | Stravix Pl |
| Abiomed | $26.13 | 2024 | Impella |
| W. L. Gore & Associates, INC. | $25.24 | 2019 | |
| Elucent Medical | $24.69 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $19.92 | 2020 | |
| Shire North American Group INC | $17.76 | 2019 | |
| Innocoll Pharmaceuticals Limited | $16.02 | 2022 | |
| Teleflex LLC | $13.97 | 2020 | |
| Leica Microsystems INC. | $13.65 | 2021 | |
| Organogenesis INC. | $8.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.